Related Experiment Videos
Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor
L Y Liu-Chen1, S X Li, R J Tallarida
1Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Abstract:
beta-Funaltrexamine (beta-FNA) was shown to be a reversible kappa agonist and an irreversible mu antagonist. [3H]beta-FNA at low concentrations (less than 10 nM) covalently binds to mu but not delta or kappa opioid receptors in brain membranes. The interaction between beta-FNA and mu opioid receptors was thought to involve two steps; a reversible ligand-receptor complex is formed before the formation of an irreversible complex, based on observations in bioassays in vitro. In this study, we investigated whether such a two-step process occurred in binding using bovine striatal membranes and determined the kinetic parameters by examining the time courses of both reversible and irreversible binding of [3H]beta-FNA to mu opioid receptors. Specific binding was defined as the difference between binding in the presence of levorphanol and dextrorphan (1 microM). Reversible binding was determined as the difference between membrane (reversible and irreversible) binding and irreversible binding. At 25 degrees, the rate of formation of irreversible [3H]beta-FNA-receptor complex increased as the concentration increased and reached a plateau at 2 nM; further increase in [3H]beta-FNA concentration did not enhance the rate of formation, indicating that the rate saturation effect exists for irreversible binding of [3H]beta-FNA to mu opioid receptors. At 10 degrees and low concentrations (less than 1 nM) of [3H]beta-FNA, appreciable reversible binding to opioid receptors occurred before any irreversible [3H]beta-FNA-receptor complex could be detected. These observations support the notion that reversible binding occurs before alkylation of the receptor. The binding of [3H]beta-FNA to mu opioid receptors was thus modeled to allow for such a two-step process: (formula; see text) A mathematical analysis method was derived to allow determination of all kinetic parameters (k+1, k-1, k2, and Kd) of such a two-step reaction. Values of k2, k+1, k-1, and Kd were determined at 10 degrees for 0.5, 0.25, and 0.125 nM [3H]beta-FNA and were found to be very similar among these three concentrations. Raising the incubation temperature from 10 degrees to 37 degrees greatly enhanced the values of k+1, k-1, and k2 without affecting Kd. At 37 degrees incubation without 200 mM NaCl significantly decreased the values of k+1, k-1, and k2 without affecting Kd. NaCl increased the irreversible binding, probably by shifting the equilibrium towards a conformation that binds more easily with beta-FNA. Under all conditions examined, the value of k-1 was found to be at least 5-fold greater than k2, indicating that the majority of the reversible complex dissociates and only a small portion proceeds to form irreversible complex. This finding is consistent with published observations that only a portion of beta-FNA binding to mu opioid receptors is irreversible. In conclusion, [3H]beta-FNA binds reversibly to mu opioid receptors before forming covalent bonding...
Insights
Beta-funaltrexamine (beta-FNA) acts as a reversible kappa agonist and irreversible mu antagonist. This study confirms [3H]beta-FNA binds reversibly to mu opioid receptors before irreversible covalent bonding.
Area of Science:
- Pharmacology
- Neuroscience
- Biochemistry
Background:
- Beta-funaltrexamine (beta-FNA) is known as a reversible kappa agonist and irreversible mu antagonist.
- Previous in vitro bioassays suggested a two-step interaction between beta-FNA and mu opioid receptors, involving reversible complex formation prior to irreversible binding.
Purpose of the Study:
- To investigate the two-step binding process of [3H]beta-FNA to mu opioid receptors in bovine striatal membranes.
- To determine the kinetic parameters governing the reversible and irreversible binding of [3H]beta-FNA.
Main Methods:
- Utilized bovine striatal membranes for binding assays.
- Examined the time courses of [3H]beta-FNA binding at varying concentrations and temperatures (10°C and 37°C).
- Defined specific binding and reversible binding to isolate binding components.
- Developed a mathematical model to determine kinetic parameters (k+1, k-1, k2, Kd).
Main Results:
- Observed a rate saturation effect for irreversible [3H]beta-FNA binding to mu opioid receptors at 2 nM.
- Demonstrated significant reversible binding preceding irreversible complex formation at low [3H]beta-FNA concentrations and 10°C.
- Kinetic parameters (k+1, k-1, k2) were temperature-dependent, while Kd remained constant.
- Sodium chloride (NaCl) enhanced irreversible binding at 37°C.
- The dissociation rate constant (k-1) was consistently higher than the irreversible rate constant (k2), indicating most reversible complexes dissociate.
Conclusions:
- The findings support a two-step mechanism for [3H]beta-FNA binding to mu opioid receptors: initial reversible binding followed by irreversible covalent modification.
- The kinetic analysis provides quantitative parameters for this binding process under various conditions.
- The dissociation of the reversible complex is favored over irreversible binding, explaining the partial irreversibility observed.